$4.08
Today
as of Aug 5, 16:51 ET
Last 30 days
Recent Press Releases & News
Molecular Partners Doses First Patients in Phase 2 Study of Biliary Tract Cancer Therapy
Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma
Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference
Overview
52-week range
$3.41
$5.36
35% of range
Avg surprise (last 2)
-22.4%
Avg reaction (last 2)
-1.9%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.45 | $-0.38 | -18.4% | +10.0% | -2.2% | earnings |
| Mon Aug 25, 2025 | Jun/2025 | $-0.67 | $-0.53 | -26.4% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.50 | — | — | — | -1.5% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 24, 2026 | Jun/2026 | OTHER | -$0.45 | -$0.67 | +32.8% |
Implied volatility — last 90 days
No IV snapshots yet for MOLN.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.